Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-02-05 00:00:00 ET · period of report 2025-02-03 · accession 0001805688-25-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-05 | 2025-02-03 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | S - Sale | $122.31 | -1,500 | 439.7K | -0.3% | -$183.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-02-03 | S | D | 1,500 | $122.31 | 439,744 | D | — | — |